Swiss-based drugmaker Actelion Ltd (ATLN.VX) had offered to buy U.S. biotech company ZS Pharma Inc (ZSPH.O) last month in a deal valued at $2.5 billion, Bloomberg reported, citing people with knowledge of the matter said.
It was unclear how ZS Pharma responded to the offer or if the two companies had held discussions, Bloomberg reported. (bloom.bg/1XQC5AR)
05:09 Sterling slides to 3-month lows on 'hard Brexit' fears12
18:21 Mark Zuckerberg takes the stand in $2 billion lawsuit claiming Oculus theft7
12:23 Morgan Stanley beats, has a record-breaking quarter for wealth management17
06:13 Pound quivers near three-month low, stocks weak before May's Brexit stance speech17